Effect on cell surface hydrophobicity and susceptibility of Helicobacter pylori to medicinal plant extracts

被引:25
作者
Annuk, H
Hirmo, S
Türi, E
Mikelsaar, M
Arak, E
Wadström, T
机构
[1] Tartu State Univ, Dept Pharm, EE-2400 Tartu, Estonia
[2] Univ Lund, Dept Med Microbiol & Infect Dis, S-22362 Lund, Sweden
[3] Tartu State Univ, Dept Microbiol, EE-2400 Tartu, Estonia
关键词
Helicobacter pylori; medicinal plant; cell surface hydrophobicity; cell aggregation; antibacterial activity;
D O I
10.1111/j.1574-6968.1999.tb13447.x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Effects of aqueous extracts of medicinal plants on ten Helicobacter pylori strains were studied by the salt aggregation test to determine the possibility to modulate their cell surface hydrophobicity and by an agar diffusion assay for detection of antimicrobial activity. It was established that aqueous extracts of bearberry and cowberry leaves enhance cell aggregation of all H. pylori strains tested by the salt aggregation test, and the extract of bearberry possessed a remarkable bacteriostatic activity. Pure tannic acid showed a result similar to that of bearberry and cowberry extracts which contained a large amount of tannins. In contrast, extracts of wild camomile and pineapple-weed, which blocked aggregation of H. pylori, contained small amounts of tannins and did not reveal any antimicrobial activity. Tannic acid seems to be the component of bearberry and cowberry aqueous extracts with the highest activity to decrease cell surface hydrophobicity as well as in antibacterial activity against H. pylori. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 22 条
[1]  
Bradley P, 1992, BRIT HERBAL COMPENDI, V1, P154
[2]  
BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
[3]  
*COUNC EUR, 1995, EUR PHARM 2
[4]   MANNOSE-RESISTANT HEMAGGLUTINATION BY CAMPYLOBACTER PYLORI [J].
EMODY, L ;
CARLSSON, A ;
LJUNGH, A ;
WADSTROM, T .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (03) :353-354
[5]  
GIBBONS RJ, 1992, INFECT DIS, P7
[6]  
KOPPEL T, 1993, EESTI ROHUTEADLANE, V4, P159
[7]   Helicobacter pylori and the risk and management of associated diseases: Gastritis, ulcer disease, atrophic gastritis and gastric cancer [J].
Kuipers, EJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 :71-88
[8]  
LACHICA RV, 1990, MICROBIAL CELL SURFA, P297
[10]   HEMAGGLUTINATION PATTERNS OF HELICOBACTER-PYLORI - FREQUENCY OF SIALIC ACID-SPECIFIC AND NONSIALIC ACID-SPECIFIC HEMAGGLUTININS [J].
LELWALAGURUGE, J ;
LJUNGH, A ;
WADSTROM, T .
APMIS, 1992, 100 (10) :908-913